Sayem Mohammad Abu Sayem MohammadAbu

Researcher Number	80772920
Other IDs	https://orcid.org/0000-0001-9903-6959
Affiliation (based on the past Project Information) *help	2019 – 2020: 慶應義塾大学, 医学部(信濃町), 特任助教
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords	Principal Investigator ICBs / ICIs / CTLs / H2O2 / Immunosuppression / VAP-1 inhibitor

Regulation of oxidative metabolic product-mediated immune suppressive tumor microenvironment to improve the efficacy of immune checkpoint blockade therapy in cancers.Principal Investigator
- Principal Investigator
  
  Sayem Mohammad Abu
- Project Period (FY)
  2019 – 2020
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Keio University

All Journal Article

[Journal Article] Inhibition of vascular adhesion protein-1 enhances the anti-tumor effects of immune checkpoint inhibitors2021
- Author(s)
  Kinoshita T, Sayem MA, Yaguchi T, Kharma B, Morii K, Kato D, Ohta S, Mashima Y, Asamura H, Kawakami Y
- Journal Title
  
  Cancer Science
  
  Volume: 112 Issue: 4 Pages: 1390-1401
- DOI
  10.1111/cas.14812
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20H03534, KAKENHI-PROJECT-19K16808, KAKENHI-PROJECT-20K21608, KAKENHI-PROJECT-21K07199, KAKENHI-PROJECT-16H06276

1. 河上裕

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results